Michael Mayer

Publications by Year

Research Areas

Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, Statistical Methods in Clinical Trials

Most-Cited Works

• → Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European cooperative Crohn's disease study VI(2000)302 cited
• → Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial(2009)119 cited
• → Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)(2011)80 cited
• → Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03(2007)41 cited
• → Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: A multicenter phase II trial (SAKK 19/05)(2012)32 cited
• → Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)(2010)26 cited
• → C-Reactive Protein Concentrations in Cerebral Spinal Fluid in Gram-positive and Gram-negative Bacterial Meningitis(2002)23 cited
• [Prognostic factors in the response of a first line chemotherapy in advanced breast cancer].(1990)
• → Real-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study(2024)6 cited
• → Stability of Cisplatin, Doxorubicin, and Mitomycin Combined with Ioversol for Chemoembolization(2001)5 cited